Literature DB >> 5706556

[On the problem of treatment of acute intermittent porphyria with ovulation inhibitors. (Studies of delta-aminolevulinic acid, porphobilinogen and total porphyrin excretion)].

V Hocevar, J G Rausch-Stroomann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5706556     DOI: 10.1007/bf01883548

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  16 in total

1.  ORAL CONTRACEPTIVES AND ACUTE INTERMITTENT PORPHYRIA.

Authors:  L WETTERBERG
Journal:  Lancet       Date:  1964-11-28       Impact factor: 79.321

2.  VARIOUS TYPES OF PORPHYRIA IN SWEDEN.

Authors:  B HAEGER-ARONSEN
Journal:  S Afr J Lab Clin Med       Date:  1963-12

3.  Increased urinary porphobilinogen and uroporphyrin after administration of stilboestrol in a case of latent porphyria.

Authors:  C J WATSON; W RUNGE; I BOSSENMAIER
Journal:  Metabolism       Date:  1962-11       Impact factor: 8.694

4.  Progesterone-induced porphyria; case report.

Authors:  E J LEVIT; J H NODINE; W H PERLOFF
Journal:  Am J Med       Date:  1957-05       Impact factor: 4.965

5.  Acute intermittent porphyria and pregnancy.

Authors:  V TRICOMI; H BAUM
Journal:  Obstet Gynecol Surv       Date:  1958-06       Impact factor: 2.347

6.  An improved method for the determination of urinary coproporphyrin and an evaluation of factors influencing the analysis.

Authors:  S SCHWARTZ; L ZIEVE; C J WATSON
Journal:  J Lab Clin Med       Date:  1951-06

7.  Onset of manifestations of hepatic porphyria in relation to the influence of female sex hormones.

Authors:  T S Zimmerman; J M McMillin; C J Watson
Journal:  Arch Intern Med       Date:  1966-09

8.  [Porphyria and pregnancy].

Authors:  F B Huber
Journal:  Schweiz Med Wochenschr       Date:  1966-06-25

9.  Oral contraceptive agents and the management of acute intermittent porphyria.

Authors:  M G Perlroth; H S Marver; D P Tschudy
Journal:  JAMA       Date:  1965-12-06       Impact factor: 56.272

10.  Urinary excretion of porphyrin precursors and coproporphyrin in healthy females on oral contraceptives.

Authors:  P Koskelo; A Eisalo; I Toivonen
Journal:  Br Med J       Date:  1966-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.